Cargando…

β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study

BACKGROUND: Portal hypertension, a common complication associated with liver cirrhosis, can result in variceal bleeding, which greatly impacts patient survival. Recently, β-arrestin-2 has been shown to predict the acute hemodynamic response to nonselective β-blocker therapy for cirrhotic portal hype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lashen, Sameh A, Shamseya, Mohammed M, Madkour, Marwa A, Abdel Salam, Radwa M, Mostafa, Sanaa S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Prospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891671/ https://www.ncbi.nlm.nih.gov/pubmed/35317175 http://dx.doi.org/10.4254/wjh.v14.i2.429

Ejemplares similares

β-Blockers Improve Presinusoidal Portal Hypertension
por: Sørensen, Michael, et al.
Publicado: (2018)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients
por: Osman, Mahmoud A, et al.
Publicado: (2016)

Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension
por: Ozturk, Omer, et al.
Publicado: (2016)

Accuracy of virtual chromoendoscopy in differentiating gastric antral vascular ectasia from portal hypertensive gastropathy: A proof of concept study
por: Al-Taee, Ahmad M, et al.
Publicado: (2021)

Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study
por: Xu, Xiangbo, et al.
Publicado: (2020)

Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients
por: Sood, Siddharth, et al.
Publicado: (2016)

Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
por: Montasser, Mohamed F, et al.
Publicado: (2017)

Can platelet count/spleen diameter ratio be used for cirrhotic children to predict esophageal varices?
por: Sezer, Oya Balci, et al.
Publicado: (2016)

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
por: Rodriguiz, Ramona M., et al.
Publicado: (2021)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett's esophagus in gastroesophageal reflux disease patients
por: Elsheaita, Ahmed, et al.
Publicado: (2020)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients
por: Picon, Rafael Veiga, et al.
Publicado: (2017)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
por: Yeh, Wen-Shuo, et al.
Publicado: (2019)

Diuretic and β-Blocker in Hypertension—Then What?
por: Ramsay, L. E.
Publicado: (1980)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Prospective validation to prevent symptomatic portal vein thrombosis after liver resection
por: Yoshida, Nao, et al.
Publicado: (2022)

Helicobacter pylori Infection in Cirrhotic Patients With Portal Hypertensive Gastropathy: A New Enigma?
por: Alarfaj, Sumaiah J., et al.
Publicado: (2022)

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
por: Zampino, Rosa, et al.
Publicado: (2018)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
por: Pani, Biswaranjan, et al.
Publicado: (2021)

Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart
por: Lymperopoulos, Anastasios, et al.
Publicado: (2019)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension
por: Kmeid, Michel, et al.
Publicado: (2020)

Catalytic activation of β-arrestin by GPCRs
por: Eichel, Kelsie, et al.
Publicado: (2018)

ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
por: Matti, Christoph, et al.
Publicado: (2020)

Superior pancreatic lymphadenectomy with portal vein priority via posterior common hepatic artery approach in laparoscopic radical gastrectomy
por: Zhang, Yu-Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b6s58jc4273iuqbvuqd5d60j0l